These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24250245)

  • 1. Efficacy of retigabine in adjunctive treatment of partial onset seizures in adults.
    Splinter MY
    J Cent Nerv Syst Dis; 2013 Oct; 5():31-41. PubMed ID: 24250245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezogabine (retigabine) and its role in the treatment of partial-onset seizures: a review.
    Splinter MY
    Clin Ther; 2012 Sep; 34(9):1845-56.e1. PubMed ID: 22917854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retigabine (ezogabine) as add-on therapy for partial-onset seizures: an update for clinicians.
    Harris JA; Murphy JA
    Ther Adv Chronic Dis; 2011 Nov; 2(6):371-6. PubMed ID: 23251762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
    Tompson DJ; Crean CS; Reeve R; Berry NS
    Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retigabine (ezogabine): in partial-onset seizures in adults with epilepsy.
    Deeks ED
    CNS Drugs; 2011 Oct; 25(10):887-900. PubMed ID: 21936589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures.
    Weisenberg JL; Wong M
    Neuropsychiatr Dis Treat; 2011; 7():409-14. PubMed ID: 21792307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of epilepsy: newly approved and developmental agents.
    Stephen LJ; Brodie MJ
    CNS Drugs; 2011 Feb; 25(2):89-107. PubMed ID: 21254787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezogabine: an evaluation of its efficacy and safety as adjunctive therapy for partial-onset seizures in adults.
    Yamada M; Welty TE
    Ann Pharmacother; 2012 Oct; 46(10):1358-67. PubMed ID: 22991134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel medications for epilepsy.
    Fattore C; Perucca E
    Drugs; 2011 Nov; 71(16):2151-78. PubMed ID: 22035515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel.
    Faulkner MA; Burke RA
    Expert Opin Drug Saf; 2013 Nov; 12(6):847-55. PubMed ID: 23883095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezogabine: a novel antiepileptic as adjunctive therapy for partial onset seizures.
    Owen RT
    Drugs Today (Barc); 2010 Nov; 46(11):815-22. PubMed ID: 21225020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of retigabine/ezogabine as adjunctive therapy in adult Asian patients with drug-resistant partial-onset seizures: A randomized, placebo-controlled Phase III study.
    Lim KS; Lotay N; White R; Kwan P
    Epilepsy Behav; 2016 Aug; 61():224-230. PubMed ID: 27376872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use.
    Large CH; Sokal DM; Nehlig A; Gunthorpe MJ; Sankar R; Crean CS; Vanlandingham KE; White HS
    Epilepsia; 2012 Mar; 53(3):425-36. PubMed ID: 22221318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of retigabine in adults with partial-onset seizures after long-term exposure: focus on unexpected ophthalmological and dermatological events.
    Brickel N; Hewett K; Rayner K; McDonald S; De'Ath J; Daniluk J; Joshi K; Boll MC; Tiamkao S; Vorobyeva O; Cooper J
    Epilepsy Behav; 2020 Jan; 102():106580. PubMed ID: 31731109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezogabine: a novel antiepileptic for adjunctive treatment of partial-onset seizures.
    Amabile CM; Vasudevan A
    Pharmacotherapy; 2013 Feb; 33(2):187-94. PubMed ID: 23386597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
    Lerche H; Daniluk J; Lotay N; DeRossett S; Edwards S; Brandt C
    Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.
    Brodie MJ; Lerche H; Gil-Nagel A; Elger C; Hall S; Shin P; Nohria V; Mansbach H;
    Neurology; 2010 Nov; 75(20):1817-24. PubMed ID: 20944074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent Clinical Development of Ezogabine/Retigabine as Adjunctive Therapy for Partial-Onset Seizures: Pharmacokinetics and Tolerability.
    Tompson DJ; Buraglio M; Andrews SM; Wheless JW
    J Pediatr Pharmacol Ther; 2016; 21(5):404-412. PubMed ID: 27877093
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy.
    Ciliberto MA; Weisenberg JL; Wong M
    Drug Healthc Patient Saf; 2012; 4():81-6. PubMed ID: 22888276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels.
    Brickel N; Gandhi P; VanLandingham K; Hammond J; DeRossett S
    Epilepsia; 2012 Apr; 53(4):606-12. PubMed ID: 22428574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.